5-72989496-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138782.3(FCHO2):āc.195A>Cā(p.Gln65His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000325 in 1,599,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.000059 ( 0 hom., cov: 33)
Exomes š: 0.000030 ( 0 hom. )
Consequence
FCHO2
NM_138782.3 missense
NM_138782.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 0.443
Genes affected
FCHO2 (HGNC:25180): (FCH and mu domain containing endocytic adaptor 2) Enables identical protein binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in clathrin-coated pit and clathrin-coated vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.022460759).
BS2
High AC in GnomAd4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO2 | NM_138782.3 | c.195A>C | p.Gln65His | missense_variant | 3/26 | ENST00000430046.7 | NP_620137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO2 | ENST00000430046.7 | c.195A>C | p.Gln65His | missense_variant | 3/26 | 1 | NM_138782.3 | ENSP00000393776.2 | ||
FCHO2 | ENST00000287761.7 | c.195A>C | p.Gln65His | missense_variant | 3/11 | 1 | ENSP00000287761.6 | |||
FCHO2 | ENST00000512348.5 | c.195A>C | p.Gln65His | missense_variant | 3/25 | 2 | ENSP00000427296.1 | |||
FCHO2 | ENST00000507345.6 | c.126-982A>C | intron_variant | 5 | ENSP00000426842.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000886 AC: 20AN: 225834Hom.: 0 AF XY: 0.000107 AC XY: 13AN XY: 121244
GnomAD3 exomes
AF:
AC:
20
AN:
225834
Hom.:
AF XY:
AC XY:
13
AN XY:
121244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000297 AC: 43AN: 1447284Hom.: 0 Cov.: 30 AF XY: 0.0000390 AC XY: 28AN XY: 718240
GnomAD4 exome
AF:
AC:
43
AN:
1447284
Hom.:
Cov.:
30
AF XY:
AC XY:
28
AN XY:
718240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74476
GnomAD4 genome
AF:
AC:
9
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.195A>C (p.Q65H) alteration is located in exon 3 (coding exon 3) of the FCHO2 gene. This alteration results from a A to C substitution at nucleotide position 195, causing the glutamine (Q) at amino acid position 65 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;.;.
Vest4
MutPred
Loss of MoRF binding (P = 0.1036);Loss of MoRF binding (P = 0.1036);Loss of MoRF binding (P = 0.1036);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at